199 related articles for article (PubMed ID: 27342974)
21. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
22. Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.
Hilditch L; Matadeen R; Goldstone DC; Rosenthal PB; Taylor IA; Stoye JP
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5771-6. PubMed ID: 21436027
[TBL] [Abstract][Full Text] [Related]
23. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
Bishop KN; Bock M; Towers G; Stoye JP
J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
[TBL] [Abstract][Full Text] [Related]
24. Origin, antiviral function and evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus Mus.
Yan Y; Buckler-White A; Wollenberg K; Kozak CA
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3259-63. PubMed ID: 19221034
[TBL] [Abstract][Full Text] [Related]
25. Characterization of producer cell-dependent restriction of murine leukemia virus replication.
Serhan F; Jourdan N; Saleun S; Moullier P; Duisit G
J Virol; 2002 Jul; 76(13):6609-17. PubMed ID: 12050374
[TBL] [Abstract][Full Text] [Related]
26. The N-terminus of murine leukaemia virus p12 protein is required for mature core stability.
Wight DJ; Boucherit VC; Wanaguru M; Elis E; Hirst EM; Li W; Ehrlich M; Bacharach E; Bishop KN
PLoS Pathog; 2014 Oct; 10(10):e1004474. PubMed ID: 25356837
[TBL] [Abstract][Full Text] [Related]
27. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses.
Marin M; Tailor CS; Nouri A; Kozak SL; Kabat D
J Virol; 1999 Nov; 73(11):9362-8. PubMed ID: 10516044
[TBL] [Abstract][Full Text] [Related]
29. Characterization of murine leukemia virus restriction in mammals.
Besnier C; Ylinen L; Strange B; Lister A; Takeuchi Y; Goff SP; Towers GJ
J Virol; 2003 Dec; 77(24):13403-6. PubMed ID: 14645596
[TBL] [Abstract][Full Text] [Related]
30. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
Saenz DT; Teo W; Olsen JC; Poeschla EM
J Virol; 2005 Dec; 79(24):15175-88. PubMed ID: 16306589
[TBL] [Abstract][Full Text] [Related]
31. A conserved mechanism of retrovirus restriction in mammals.
Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
[TBL] [Abstract][Full Text] [Related]
32. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
33. Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins.
Taylor WR; Stoye JP
BMC Struct Biol; 2004 Jan; 4():1. PubMed ID: 14715087
[TBL] [Abstract][Full Text] [Related]
34. Ancient Evolutionary Origin and Positive Selection of the Retroviral Restriction Factor
Boso G; Buckler-White A; Kozak CA
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976659
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
Ohkura S; Horie M; Shimizu M; Nakagawa S; Osanai H; Miyagawa Y; Morita R
J Virol; 2023 Mar; 97(3):e0180322. PubMed ID: 36779757
[TBL] [Abstract][Full Text] [Related]
36. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.
Halemano K; Barrett BS; Li SX; Harper MS; Smith DS; Heilman KJ; Santiago ML
PLoS One; 2013; 8(3):e60500. PubMed ID: 23533681
[TBL] [Abstract][Full Text] [Related]
37. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
38. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
39. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
40. [Retroviral restriction factors : from Fv1 to TRIM5α].
Cissé A; Darbandi-Tehrani K; Derache A; El Houry S; Marlin R; Pernet O; Nisole S
Virologie (Montrouge); 2006 Apr; 10(2):119-127. PubMed ID: 34679269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
